Story perspectives

GLP-1 Medications Linked to 42% Drop in Mental Health Hospitalizations

4/7/2026

Summary

Story summary

A study involving nearly 100,000 participants found that glucagon-like peptide-1 (GLP-1) medications such as semaglutide (Ozempic) are associated with improved mental health, including a 42% reduction in hospitalizations for mental health issues and lower rates of depression and anxiety.
Hospitalizations related to substance use dropped by 47%.
Researchers suggest benefits may stem from improved body image, better glycemic control, and neurobiological changes.
The exact reasons remain unclear.

1 of 1

Story summary

A study involving nearly 100,000 participants found that glucagon-like peptide-1 (GLP-1) medications such as semaglutide (Ozempic) are associated with improved mental health, including a 42% reduction in hospitalizations for mental health issues and lower rates of depression and anxiety.
Hospitalizations related to substance use dropped by 47%.
Researchers suggest benefits may stem from improved body image, better glycemic control, and neurobiological changes.
The exact reasons remain unclear.